Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hcgoncology.com | |
Market Cap | 5,072.55 Cr. | |
Enterprise Value(EV) | 5,390.34 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.66 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 136.76 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.15 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 61.59 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 5.91 | Calculated using Price: 364.20 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 13.93 Cr. | 139,279,287 Shares |
FaceValue | 10 | |
About Healthcare Global Enterprises Ltd. | ||
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand. |
1 Day |
|
+0.83% |
1 Week |
|
-0.44% |
1 Month |
|
-0.70% |
3 Month |
|
-3.00% |
6 Month |
|
+15.59% |
1 Year |
|
+24.48% |
2 Year |
|
+41.67% |
5 Year |
|
+82.05% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 1.75 | 0.64 | 5.38 | 3.71 | -6.48 | -29.68 | -43.32 | 5.16 | 2.06 | |
Return on Capital Employed (%) | 6.41 | 5.60 | 7.22 | 7.59 | 3.46 | 1.65 | -9.66 | 15.17 | 11.69 | |
Return on Assets (%) | 0.64 | 0.25 | 2.06 | 1.29 | -2.03 | -6.51 | -10.46 | 1.85 | 0.78 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 279 | 426 | 433 | 515 | 477 | 381 | 697 | 870 | 861 | 858 | |
Non Curr. Liab. | 279 | 306 | 354 | 483 | 557 | 1,232 | 822 | 860 | 871 | 916 | |
Curr. Liab. | 187 | 263 | 366 | 359 | 547 | 576 | 465 | 470 | 570 | 637 | |
Minority Int. | 25 | 33 | 57 | 64 | 46 | 39 | 17 | 13 | 9 | 3 | |
Equity & Liab. | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 | 2,413 | |
Non Curr. Assets | 648 | 800 | 966 | 1,200 | 1,354 | 1,923 | 1,566 | 1,711 | 1,730 | 1,820 | |
Curr. Assets | 122 | 227 | 244 | 220 | 273 | 304 | 435 | 502 | 580 | 594 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 770 | 1,027 | 1,210 | 1,421 | 1,627 | 2,227 | 2,001 | 2,214 | 2,311 | 2,413 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,814 | |
Other Income | 5 | 4 | 10 | 19 | 10 | 10 | 21 | 16 | 32 | 14 | |
Total Income | 524 | 588 | 710 | 848 | 986 | 1,103 | 1,030 | 1,410 | 1,723 | 1,828 | |
Total Expenditure | -443 | -499 | -595 | -716 | -853 | -923 | -887 | -1,160 | -1,411 | -1,503 | |
PBIDT | 81 | 89 | 115 | 132 | 133 | 179 | 144 | 251 | 312 | 325 | |
Interest | -34 | -38 | -23 | -42 | -70 | -138 | -119 | -98 | -104 | -105 | |
Depreciation | -39 | -44 | -57 | -71 | -85 | -148 | -159 | -158 | -163 | -167 | |
Taxation | 2 | 2 | -12 | -10 | 3 | -6 | 8 | -49 | -27 | -29 | |
Exceptional Items | -5 | -6 | 11 | -93 | 95 | ||||||
PAT | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 24 | |
Minority Interest | -4 | -4 | -1 | 4 | 6 | 19 | 28 | 15 | 12 | 13 | |
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 1 | -1 | 22 | 21 | -25 | -107 | -193 | 54 | 29 | 37 | |
Adjusted EPS | 0 | 0 | 3 | 2 | -3 | -12 | -15 | 4 | 2 | 3 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 50 | 60 | 73 | 91 | 98 | 99 | 130 | 121 | 220 | 252 | |
Cash Fr. Inv. | -58 | -80 | -204 | -210 | -282 | -238 | -101 | -171 | 125 | -133 | |
Cash Fr. Finan. | 23 | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | |
Net Change | 15 | 2 | 85 | -29 | -23 | -56 | -30 | 62 | 190 | -22 | |
Cash & Cash Eqvt | 25 | 25 | 80 | 51 | 27 | -29 | -59 | 3 | 193 | 171 |
Fri, 17 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of the earnings call held on November 10 2023 with analysts/investors to discuss on the unaudited financial results for the quarter and half year ended Sept 30 2023 |
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2023 |
Fri, 10 Nov 2023
Earnings Call Recording Audio rcording of Earnings call held with Analysts/Investors to discuss the unaudited financial results of the Company for the quarter and half year ended Sept 30 2023 is made available on the website of the Company. |
Mon, 11 Dec 2023 |
|
|
|
|
|